Impact of common risk factors of fibrosis progression in chronic hepatitis C
View abstract on PubMed
Summary
This summary is machine-generated.Most factors accelerating liver fibrosis progression in chronic hepatitis C are unmodifiable. Key contributors include age at infection, sex, route of infection, and hepatitis C virus (HCV) genotype, alongside specific genetic variants.
Area Of Science
- Hepatology and Viral Gastroenterology
- Clinical Research
- Genetics and Genomics
Background
- Chronic hepatitis C (HCV) progression to advanced liver disease varies significantly among patients.
- Accurate patient profiling is crucial for predicting fibrosis progression and managing liver disease risk.
- Understanding the multifactorial drivers of liver fibrosis is essential for targeted interventions.
Purpose Of The Study
- To determine the relative contributions of various factors to liver fibrosis progression in chronic hepatitis C.
- To identify key risk factors for accelerated fibrosis progression rate (FPR) in a large patient cohort.
- To validate findings across multiple independent cohorts and through meta-analysis.
Main Methods
- Analysis of 1461 chronic hepatitis C patients with estimated infection dates and liver biopsies.
- Logistic regression used to identify risk factors for accelerated FPR (≥ 0.13 Metavir units/year).
- Assessment of factors including demographics, lifestyle, coinfections, and genetic polymorphisms (SNPs).
Main Results
- Age at infection (28.7%), route of infection (16.5%), sex (8.2%), and HCV genotype (7.9%) were significant contributors to accelerated FPR.
- Specific genetic variants (rs738409, rs4374383, rs910049) also significantly increased the risk of accelerated FPR.
- Significant alcohol consumption, BMI, HIV coinfection, and diabetes did not show a significant association with accelerated FPR.
Conclusions
- The primary drivers of accelerated liver fibrosis progression in chronic hepatitis C are largely unmodifiable factors.
- Age, sex, route of infection, HCV genotype, and specific genetic variations are key determinants of fibrosis progression.
- These findings underscore the importance of considering demographic and genetic factors in managing chronic hepatitis C.

